Vision
We Make Standards
Mission
We are developing an exosome-based therapeutics targeting refractory solid tumors.
-
R&D + upstream processing
Research personnel specialized in biopharmaceutical production and quality control
-
QC & downstream processing
Decision for the modality considering of delivery, versatility and low toxicity, etc.
Leadership
-
- Seoul National University, Department of Bioscience, Ph.D
- Celltrion, Inc. (前)
Lead in key business related to biosimilar approval- Lead CMC and MoA analysis
– Remsima® (CT-P13, Remicade biosimilar)
– Truxima® (CT-P10, Mabthera biosimilar)
– Herzuma® (CT-P6, Herceptin biosimilar)
- Lead Clinical Alternative Study for Expanded Indication
– Remsima®, Truxima® - Lead clinical analysis (PK, ADA, Nab) development
– Herzuma®, Truxima®, Remsima® - Responses to product approval inspections by major regulatory agencies – EMA, FDA, etc.
- Liver disease treatment Godex® (CELLTRION PHARM)
– Development and FDA approval lead for the shipment testing method of raw materials
- Lead CMC and MoA analysis
-
- Seoul National University School of Biological Sciences Ph.D
- Harvard Medical School – Post Doc.
- Development of stem cell therapy using mRNA
- (Advisor Professor Derrick Rossi – Founder of Moderna)
- Toolgen – Research Director (前)
- CAR-T treatment using CRISPR genetic scissors
- Development of peripheral nervous system disorder treatment
- Handong Global University – Professor of Life Sciences (現)
- Development of anticancer drugs using stem cell-derived exosomes
- Development of anti-inflammatory therapeutics
-
- Ph.D. in Department of Life Sciences, Pohang University of Science and Technology (POSTECH).
- Toolgen Senior Researcher (前)
- Development of anti-cancer immunotherapy
- Development of gene editing therapy and lead for immune cell therapy
- 150 billion technology export performance
-
- Seoul National University, School of Biological Sciences, M.A.
- Celltrion Chemical Immunity QC Raw Material Analysis Team (前)
- HPLC, ICP-MS Professional Operator
- Development of Celtrion’s raw material analysis method and establishment of raw material quality management system
×
Sunghwan Kim (CEO)
×
Jungmin Lee (CSO)
×
Yoonyoung Kim (Director, Research Development)
×